BRIEF-uniQure announces FDA breakthrough therapy designation for AMT-060 in hemophilia B
* uniQure announces FDA breakthrough therapy designation for AMT-060 in hemophilia B Source text for Eikon: Further company coverage: [Source]
Publication Date:Origin: reuters.com
Category: rbssHealthcareNews
Topics: hemophilia, designation, therapy, breakthrough, announces, coverage, company, Further, Eikon, B Source, for AMT-060, uniQure, AMT-060, BRIEF-uniQure
Source: http://feeds.reuters.com/~r/reuters/UShealthcareNews/~3/p4RjMACHVBg/idUSASB0AXBY